-
Symbol
-
ALGS on Nasdaq
-
Investment type
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
289,169 shares
-
Security Ownership %
-
5.4%
Shares, Excluding Options vs Price
Woodline Partners LP ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)
17 Feb 2026 - Woodline Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 289,169 shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS).
This represents 5.4% ownership of the company.
In their previous filing dated 14 Nov 2025, Woodline Partners LP had reported owning 468,199 shares, indicating a decrease of +38%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.